DNA methylation, a hand behind neurodegenerative diseases

Frontiers in Aging Neuroscience

Volumn 5, Issue DEC, 2013, Pages

  Lu, Haoyang ^a   Liu, Xinzhou ^a   Deng, Yulin ^a   Qing, Hong ^a  

^a BEIJING INSTITUTE OF TECHNOLOGY   (China)

Author keywords

Alzheimer's disease; Amyotrophic lateral sclerosis; DNA methylation; Huntington's disease; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; BETA SECRETASE 1; CYTOSINE; GLUTAMATE TRANSPORTER; GLYCOGEN SYNTHASE KINASE 3BETA; METHYL GROUP; PROTEIN; PSEN1 PROTEIN; RIBOSOME DNA; TAU PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CHROMATIN STRUCTURE; DEGENERATIVE DISEASE; DEMENTIA; DNA DEGRADATION; DNA METABOLISM; DNA METHYLATION; DNA MODIFICATION; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE SILENCING; HEREDITY; HISTONE ACETYLATION; HUMAN; HUNTINGTON CHOREA; NERVE CELL PLASTICITY; NONHUMAN; PARKINSON DISEASE; PROMOTER REGION; REVIEW;

EID: 84895817996     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2013.00085     Document Type: Review

References (149)

1. Babenko, O., Kovalchuk, I., and Metz, G. A. (2012). Epigenetic programming of neurodegenerative diseases by an adverse environment. Brain Res. 1444, 96-111. doi: 10.1016/j.brainres.2012.01.038.
2. Bakulski, K. M., Dolinoy, D. C., Sartor, M. A., Paulson, H. L., Konen, J. R., Lieberman, A. P., et al. (2012). Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex. J. Alzheimers Dis. 29, 571-588. doi: 10.3233/JAD-2012-111223.
3. Barrachina, M., and Ferrer, I. (2009). DNA methylation of Alzheimer disease and tauopathy-related genes in postmortem brain. J. Neuropathol. Exp. Neurol. 68, 880-891. doi: 10.1097/NEN.0b013e3181af2e46.
4. Basha, M. R., Wei, W., Bakheet, S. A., Benitez, N., Siddiqi, H. K., Ge, Y. W., et al. (2005). The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain. J. Neurosci. 25, 823-829. doi: 10.1523/JNEUROSCI.4335-04.2005.
5. Behnkrappa, A., and Doerfler, W. (1994). Enzymatic amplification of synthetic oligodeoxyribonucleotides: implication for triplet repeat expansions in the human genome. Human Mutat. 3, 19-24. doi: 10.1002/humu.1380030104.
6. Bensemain, F., Hot, D., Ferreira, S., Dumont, J., Bombois, S., Maurage, C. A., et al. (2009). Evidence for induction of the ornithine transcarbamylase expression in Alzheimer's disease. Mol. Psychiatr. 14, 106-116. doi: 10.1038/sj.mp.4002089.
7. Bestor, T. H. (2000). The DNA methyltransferases of mammals. Hum. Mol. Genet. 9, 2395-2402. doi: 10.1093/hmg/9.16.2395.
8. Bhutani, N., Burns, D. M., and Blau, H. M. (2011). DNA demethylation dynamics. Cell 146, 866-872. doi: 10.1016/j.cell.2011.08.042.
9. Bihaqi, S. W., Huang, H., Wu, J., and Zawia, N. H. (2011). Infant exposure to lead (Pb) and epigenetic modifications in the aging primate brain: implications for Alzheimer's disease. J. Alzheimers Dis. 27, 819-833. doi: 10.3233/JAD-2011-111013.
10. Bihaqi, S. W., and Zawia, N. H. (2012). Alzheimer's disease biomarkers and epigenetic intermediates following exposure to Pb in vitro. Curr. Alzheimer Res. 9, 555-562.
11. Bird, A. (2002). DNA methylation patterns and epigenetic memory. Genes Dev. 16, 6-21. doi: 10.1101/gad.947102.
12. Blandini, F., Fancellu, R., Martignoni, E., Mangiagalli, A., Pacchetti Samuele, A., et al. (2001). Plasma homocysteine and L-DOPA metabolism in patients with Parkinson disease. Clin. Chem. 47, 1102-1104.
13. Bollati, V., Galimberti, D., Pergoli, L., Dalla Valle, E., Barretta, F., Cortini, F., et al. (2011). DNA methylation in repetitive elements and Alzheimer disease. Brain Behav. Immun. 25, 1078-1083. doi: 10.1016/j.bbi.2011.01.017.
14. Bonsch, D., Lenz, B., Kornhuber, J., and Bleich, S. (2005). DNA hypermethylation of the alpha synuclein promoter in patients with alcoholism. Neuroreport 16, 167-170. doi: 10.1097/00001756-200502080-00020.
15. Brattstrom, L. (2001). Plasma homocysteine and MTHFR C677T genotype in levodopa-treated patients with PD. Neurology 56, 281. doi: 10.1212/WNL.56.2.281.
16. Brohede, J., Rinde, M., Winblad, B., and Graff, C. (2010). A DNA methylation study of the amyloid precursor protein gene in several brain regions from patients with familial Alzheimer disease. J. Neurogenet. 24, 179-181. doi: 10.3109/01677063.2010.503978.
17. Byun, C. J., Seo, J., Jo, S. A., Park, Y. J., Klug, M., Rehli, M., et al. (2012). DNA methylation of the 5'-untranslated region at +298 and +351 represses BACE1 expression in mouse BV-2 microglial cells. Biochem. Biophys. Res. Commun. 417, 387-392. doi: 10.1016/j.bbrc.2011.11.123.
18. Cai, M., Tian, J., Zhao, G. H., Luo, W., and Zhang, B. R. (2011). Study of methylation levels of parkin gene promoter in Parkinson's disease patients. Int. J. Neurosci. 121, 497-502. doi: 10.3109/00207454.2011.580866.
19. Cai, Y., Liu, S., Sothern, R. B., Xu, S., and Chan, P. (2010). Expression of clock genes Per1 and Bmal1 in total leukocytes in health and Parkinson's disease. Eur. J. Neurol. 17, 550-554. doi: 10.1111/j.1468-1331.2009.02848.x.
20. Chen, H., Dzitoyeva, S., and Manev, H. (2012). Effect of aging on 5-hydroxymethylcytosine in the mouse hippocampus. Restor. Neurol. Neurosci. 30, 237-245. doi: 10.3233/RNN-2012-110223.
21. Chen, K. L., Wang, S. S., Yang, Y. Y., Yuan, R. Y., Chen, R. M., and Hu, C. J. (2009). The epigenetic effects of amyloid-beta(1-40) on global DNA and neprilysin genes in murine cerebral endothelial cells. Biochem. Biophys. Res. Commun. 378, 57-61. doi: 10.1016/j.bbrc.2008.10.173.
22. Chestnut, B. A., Chang, Q., Price, A., Lesuisse, C., Wong, M., and Martin, L. J. (2011). Epigenetic regulation of motor neuron cell death through DNA methylation. J. Neurosci. 31, 16619-16636. doi: 10.1523/JNEUROSCI.1639-11.2011.
23. Chouliaras, L., Mastroeni, D., Delvaux, E., Grover, A., Kenis, G., Hof, P. R., et al. (2013). Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer's disease patients. Neurobiol. Aging 34, 2091-2099. doi: 10.1016/j.neurobiolaging.2013.02.021.
24. Chow, V. W., Mattson, M. P., Wong, P. C., and Gleichmann, M. (2010). An overview of APP processing enzymes and products. Neuromol. Med. 12, 1-12. doi: 10.1007/s12017-009-8104-z.
25. Clarke, R., Smith, A. D., Jobst, K. A., Refsum, H., Sutton, L., and Ueland, P. M. (1998). Folate, vitamin B-12, and serum total homocysteine levels in confirmed Alzheimer disease Arch. Neurol. 55, 1449-1455. doi: 10.1001/archneur.55.11.1449.
26. Day, J. J., and Sweatt, J. D. (2010). DNA methylation and memory formation. Nat. Neurosci. 13, 1319-1323. doi: 10.1038/nn.2666.
27. de Boni, L., Tierling, S., Roeber, S., Walter, J., Giese, A., and Kretzschmar, H. A. (2011). Next-Generation sequencing reveals regional differences of the alpha-synuclein methylation state independent of Lewy body disease Neuromol. Med. 13, 310-320. doi: 10.1007/s12017-011-8163-9.
28. de Carvalho, M., and Swash, M. (2011). Amyotrophic lateral sclerosis: an update. Curr. Opin. Neurol. 24, 497-503. doi: 10.1097/WCO.0b013e32834916a9.
29. de Lau, L. M. L., and Breteler, M. M. B. (2006). Epidemiology of Parkinson's disease. Lancet Neurol. 5, 525-535. doi: 10.1016/S1474-4422(06)70471-9.
30. Desplats, P., Spencer, B., Coffee, E., Patel, P., Michael, S., Patrick, C., et al. (2011). Alpha-synuclein sequesters Dnmt1 from the nucleus: a novel mechanism for epigenetic alterations in Lewy body diseases. J. Biol. Chem. 286, 9031-9037. doi: 10.1074/jbc. C110.212589.
31. Ding, Q., Markesbery, W. R., Chen, Q., Li, F., and Keller, J. N. (2005). Ribosome dysfunction is an early event in Alzheimer's disease. J. Neurosci. 25, 9171-9175. doi: 10.1523/JNEUROSCI.3040-05.2005.
32. Dodge, J. E., Ramsahoye, B. H., Wo, Z. G., Okano, M., and Li, E. (2002). De novo methylation of MMLV provirus in embryonic stem cells: CpG versus non-CpG methylation. Gene 289, 41-48. doi: 10.1016/S0378-1119(02)00469-9.
33. Duan, W., Ladenheim, B., Cutler, R. G., Kruman, I. I., Cadet, J. L., and Mattson, M. P. (2002). Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic, neurons in models of Parkinson's disease. J. Neurochem. 80, 101-110. doi: 10.1046/j.0022-3042.2001.00676.x.
34. Edwards, J. R., O'Donnell, A. H., Rollins, R. A., Peckham, H. E., Lee, C., Milekic, M. H., et al. (2010). Chromatin and sequence features that define the fine and gross structure of genomic methylation patterns. Genome Res. 20, 972-980. doi: 10.1101/gr.101535.109.
35. Farrer, L. A., Cupples, L. A., Kiely, D. K., Conneally, P. M., and Myers, R. H. (1992). Inverse relationship between age at onset of huntington disease and paternal age suggests involvement of genetic imprinting. Am. J. Hum. Genet. 50, 528-535.
36. Fatemi, M., and Wade, P. A. (2006). MBD family proteins: reading the epigenetic code. J. Cell. Sci. 119, 3033-3037. doi: 10.1242/jcs.03099.
37. Ferraiuolo, L., Kirby, J., Grierson, A. J., Sendtner, M., and Shaw, P. J. (2011). Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat. Rev. Neurol. 7, 616-630. doi: 10.1038/nrneurol.2011.152.
38. Filippova, G. N., Thienes, C. P., Penn, B. H., Cho, D. H., Hu, Y. J., Moore, J. M., et al. (2001). CTCF-binding sites flank CTG/CAG repeats and form a methylation-sensitive insulator at the DM1 locus. Nat. Genet. 28, 335-343. doi: 10.1038/ng570.
39. Fraga, M. F., Ballestar, E., Paz, M. F., Ropero, S., Setien, F., Ballestar, M. L., et al. (2005). Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl. Acad. Sci. U.S.A. 102, 10604-10609. doi: 10.1073/pnas.0500398102.
40. Furuya, T. K., da Silva, P. N., Payao, S. L., Rasmussen, L. T., de Labio, R. W., Bertolucci, P. H., et al. (2012a). SORL1 and SIRT1 mRNA expression and promoter methylation levels in aging and Alzheimer's disease. Neurochem. Int. 61, 973-975. doi: 10.1016/j.neuint.2012.07.014.
41. Furuya, T. K., Silva, P. N., Payao, S. L., Bertolucci, P. H., Rasmussen, L. T., de Labio, R. W., et al. (2012b). Analysis of SNAP25 mRNA expression and promoter DNA methylation in brain areas of Alzheimer's disease patients. Neuroscience 220, 41-46. doi: 10.1016/j.neuroscience.2012.06.035.
42. Fuso, A., Cavallaro, R. A., Nicolia, V., and Scarpa, S. (2012a). PSEN1 promoter demethylation in hyperhomocysteinemic TgCRND8 mice is the culprit, not the consequence. Curr. Alzheimer Res. 9, 527-535.
43. Fuso, A., Nicolia, V., Ricceri, L., Cavallaro, R. A., Isopi, E., Mangia, F., et al. (2012b). S-adenosylmethionine reduces the progress of the Alzheimer-like features induced by B-vitamin deficiency in mice. Neurobiol. Aging 33, 1482.e1-1482.e16. doi: 10.1016/j.neurobiolaging.2011.12.013.
44. Fuso, A., Cavallaroa, R. A., Zampellia, A., D'Anselmia, F., Piscopob, P., Confalonib, A., et al. (2007). γ-secretase is differentially modulated by alteration of homocysteine cycle in neuroblastoma and glioblastoma cells. J. Alzheimers Dis. 11, 275-290.
45. Fuso, A., Nicolia, V., Cavallaro, R. A., Ricceri, L., D'Anselmi, F., Coluccia, P., et al. (2008). B-vitamin deprivation induces hyperhomocysteinemia and brain S-adenosylhomocysteine, depletes brain S-adenosylmethionine, and enhances PS1 and BACE expression and amyloid-beta deposition in mice. Mol. Cell. Neurosci. 37, 731-746. doi: 10.1016/j.mcn.2007.12.018.
46. Fuso, A., Nicolia, V., Cavallaro, R. A., and Scarpa, S. (2011a). DNA methylase and demethylase activities are modulated by one-carbon metabolism in Alzheimer's disease models. J. Nutr. Biochem. 22, 242-251. doi: 10.1016/j.jnutbio.2010.01.010.
47. Fuso, A., Nicolia, V., Pasqualato, A., Fiorenza, M. T., Cavallaro, R. A., and Scarpa, S. (2011b). Changes in Presenilin 1 gene methylation pattern in diet-induced B vitamin deficiency. Neurobiol. Aging 32, 187-199. doi: 10.1016/j.neurobiolaging.2009.02.013.
48. Fuso, A., and Scarpa, S. (2011). One-carbon metabolism and Alzheimer's disease: is it all a methylation matter? Neurobiol. Aging 32, 1192-1195. doi: 10.1016/j.neurobiolaging.2011.01.012.
49. Fuso, A., Seminara, L., Cavallaro, R. A., D'Anselmi, F., and Scarpa, S. (2005). S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production. Mol. Cell. Neurosci. 28, 195-204. doi: 10.1016/j.mcn.2004.09.007.
50. Goll, M. G., Kirpekar, F., Maggert, K. A., Yoder, J. A., Hsieh, C. L., Zhang, X., et al. (2006). Methylation of tRNAAsp by the DNA methyltransferase homolog Dnmt2. Science 311, 395-398. doi: 10.1126/science.1120976.
51. Gorbunova, V., Seluanov, A., Mittelman, D., and Wilson, J. H. (2004). Genome-wide demethylation destabilizes CTG. CAG trinucleotide repeats in mammalian cells. Hum. Mol. Genet. 13, 2979-2989. doi: 10.1093/hmg/ddh317.
52. Gu, X., Sun, J., Li, S., Wu, X., and Li, L. (2013). Oxidative stress induces DNA demethylation and histone acetylation in SH-SY5Y cells: potential epigenetic mechanisms in gene transcription in Abeta production. Neurobiol. Aging 34, 1069-1079. doi: 10.1016/j.neurobiolaging.2012.10.013.
53. Guan, J. Z., Guan, W. P., Maeda, T., and Makino, N. (2012). Effect of vitamin E administration on the elevated oxygen stress and the telomeric and subtelomeric status in Alzheimer's disease. Gerontology 58, 62-69. doi: 10.1159/000327821.
54. Guan, J. Z., Maeda, T., Sugano, M., Oyama, J., Higuchi, Y., Suzuki, T., et al. (2008). A percentage analysis of the telomere length in Parkinson's disease patients. J. Gerontol. A Biol. Sci. Med. Sci. 63, 467-473. doi: 10.1093/gerona/63.5.467.
55. Guo, J. U., Su, Y., Zhong, C., Ming, G. L., and Song, H. (2011a). Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell 145, 423-434. doi: 10.1016/j.cell.2011.03.022.
56. Guo, X., Wu, X., Ren, L., Liu, G., and Li, L. (2011b). Epigenetic mechanisms of amyloid-beta production in anisomycin-treated SH-SY5Y cells. Neuroscience 194, 272-281. doi: 10.1016/j.neuroscience.2011.07.012.
57. Haines, T. R., Rodenhiser, D. I., and Ainsworth, P. J. (2001). Allele-specific non-CpG methylation of the Nf1 gene during early mouse development. Dev. Biol. 240, 585-598. doi: 10.1006/dbio.2001.0504.
58. Hon, G. C., Rajagopal, N., Shen, Y., Mccleary, D. F., Yue, F., Dang, M. D., et al. (2013). Epigenetic memory at embryonic enhancers identified in DNA methylation maps from adult mouse tissues. Nat. Genet. 45, 1198-1206. doi: 10.1038/ng.2746.
59. Hood, S., Cassidy, P., Cossette, M. P., Weigl, Y., Verwey, M., Robinson, B., et al. (2010). Endogenous dopamine regulates the rhythm of expression of the clock protein PER2 in the rat dorsal striatum via daily activation of D2 dopamine receptors. J. Neurosci. 30, 14046-14058. doi: 10.1523/JNEUROSCI.2128-10.2010.
60. Horvath, S., Zhang, Y., Langfelder, P., Kahn, R. S., Boks, M. P., van Eijk, K., et al. (2012). Aging effects on DNA methylation modules in human brain and blood tissue. Genome Biol. 13:R97. doi: 10.1186/gb-2012-13-10-r97.
61. Hotchkiss, R. D. (1948). The quantitative separation of purines, pyrimidines, and nucleosides by paper chromatography. J. Biol. Chem. 175, 315-332.
62. Ittner, L. M., and Gotz, J. (2011). Amyloid-beta and tau-a toxic pas de deux in Alzheimer's disease. Nat. Rev. Neurosci. 12, 65-72. doi: 10.1038/nrn2967.
63. Iwamoto, K., Bundo, M., Ueda, J., Oldham, M. C., Ukai, W., Hashimoto, E., et al. (2011). Neurons show distinctive DNA methylation profile and higher interindividual variations compared with non-neurons. Genome Res. 21, 688-696. doi: 10.1101/gr.112755.110.
64. Iwata, N., Tsubuki, S., Takaki, Y., Watanabe, K., Sekiguchi, M., Hosoki, E., et al. (2000). Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat. Med. 6, 143-150. doi: 10.1038/77399.
65. Jiang, Q., Lee, C. Y., Mandrekar, S., Wilkinson, B., Cramer, P., Zelcer, N., et al. (2008). ApoE promotes the proteolytic degradation of Abeta. Neuron 58, 681-693. doi: 10.1016/j.neuron.2008.04.010.
66. Jin, H., Kanthasamy, A., Ghosh, A., Yang, Y., Anantharam, V., and Kanthasamy, A. G. (2011). alpha-Synuclein negatively regulates protein kinase Cdelta expression to suppress apoptosis in dopaminergic neurons by reducing p300 histone acetyltransferase activity. J. Neurosci. 31, 2035-2051. doi: 10.1523/JNEUROSCI.5634-10.2011.
67. Jowaed, A., Schmitt, I., Kaut, O., and Wullner, U. (2010). Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains. J. Neurosci. 30, 6355-6359. doi: 10.1523/JNEUROSCI.6119-09.2010.
68. Kagara, I., Enokida, H., Kawakami, K., Matsuda, R., Toki, K., Nishimura, H., et al. (2008). CpG hypermethylation of the UCHL1 gene promoter is associated with pathogenesis and poor prognosis in renal cell carcinoma. J. Urology 180, 343-351. doi: 10.1016/j.juro.2008.02.044.
69. Kalbe, E., Kessler, J., Calabrese, P., Smith, R., Passmore, A. P., Brand, M., et al. (2004). DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int. J. Geriatr. Psychiatry 19, 136-143. doi: 10.1002/gps.1042.
70. Kaut, O., Schmitt, I., and Wullner, U. (2012). Genome-scale methylation analysis of Parkinson's disease patients' brains reveals DNA hypomethylation and increased mRNA expression of cytochrome P450 2E1. Neurogenetics 13, 87-91. doi: 10.1007/s10048-011-0308-3.
71. Khan, A. A., Mao, X. O., Banwait, S., Jin, K., and Greenberg, D. A. (2007). Neuroglobin attenuates-amyloid neurotoxicity in vitro and transgenic Alzheimer phenotype in vivo. Proc. Natl. Acad. Sci. U.S.A. 104, 19114-19119. doi: 10.1073/pnas.0706167104.
72. Kiernan, M., Vucic, S., Cheah, B., Turner, M., Eisen, A., Hardiman, O., et al. (2011). Amyotrophic lateral sclerosis. Lancet 377, 942-955. doi: 10.1016/S0140-6736(10)61156-7.
73. Kim, W. Y., and Sharpless, N. E. (2006). The regulation of INK4/ARF in cancer and aging. Cell 127, 265-275. doi: 10.1016/j.cell.2006.10.003.
74. Kong, M., Ba, M., Liang, H., Ma, L., Yu, Q., Yu, T., et al. (2012). 5'-Aza-dC sensitizes paraquat toxic effects on PC12 cell. Neurosci. Lett. 524, 35-39. doi: 10.1016/j.neulet.2012.07.001.
75. Kriaucionis, S., and Heintz, N. (2009). The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324, 929-930. doi: 10.1126/science.1169786.
76. Kurochkin, I. V., and Goto, S. (1994). Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett. 345, 33-37. doi: 10.1016/0014-5793(94)00387-4.
77. Labonte, B., Suderman, M., Maussion, G., Navaro, L., Yerko, V., Mahar, I., et al. (2012). Genomer-wide epigenetic regulation by early-life trauma. Arch. Gen. Psychiatry 69, 722-731. doi: 10.1001/archgenpsychiatry.2011.2287.
78. Laffita-Mesa, J., Bauer, P., Kouri, V., Serrano, L., Roskams, J., Gotay, D., et al. (2012). Epigenetics DNA methylation in the core ataxin-2 gene promoter: novel physiological and pathological implications. Hum. Genet. 131, 625-638. doi: 10.1007/s00439-011-1101-y.
79. Lahiri, D. K., and Maloney, B. (2012). The "LEARn" (latent early-life associated regulation) model: an epigenetic pathway linking metabolic and cognitive disorders. J. Alzheimers Dis. 30(Suppl. 2), S15-S30. doi: 10.3233/JAD-2012-120373.
80. Lahiri, D. K., Zawia, N. H., Greig, N. H., Sambamurti, K., and Maloney, B. (2008). Early-life events may trigger biochemical pathways for Alzheimer's disease: the "LEARn" model. Biogerontology 9, 375-379. doi: 10.1007/s10522-008-9162-6.
81. Lahut, S., Omur, O., Uyan, O., Agim, Z. S., Ozoguz, A., Parman, Y., et al. (2012). ATXN2 and its neighbouring gene SH2B3 are associated with increased ALS risk in the Turkish population. PLoS ONE 7:e42956. doi: 10.1371/journal.pone.0042956.
82. Libby, R. T., Hagerman, K. A., Pineda, V. V., Lau, R., Cho, D. H., Baccam, S. L., et al. (2008). CTCF cis-regulates trinucleotide repeat instability in an epigenetic manner: a novel basis for mutational hot spot determination. PLoS Genet. 4:e1000257. doi: 10.1371/journal.pgen.1000257.
83. Lin, H. C., Song, T. Y., and Hu, M. L. (2011). S-Adenosylhomocysteine enhances DNA damage through increased beta-amyloid formation and inhibition of the DNA-repair enzyme OGG1b in microglial BV-2 cells. Toxicology 290, 342-349. doi: 10.1016/j.tox.2011.10.016.
84. Lin, Q., Ding, H., Zheng, Z., Gu, Z., Ma, J., Chen, L., et al. (2012). Promoter methylation analysis of seven clock genes in Parkinson's disease. Neurosci. Lett. 507, 147-150. doi: 10.1016/j.neulet.2011.12.007.
85. Lister, R., Mukamel, E. A., Nery, J. R., Urich, M., Puddifoot, C. A., Johnson, N. D., et al. (2013). Global epigenomic reconfiguration during mammalian brain development. Science 341, 1237905. doi: 10.1126/science.1237905.
86. Lister, R., Pelizzola, M., Dowen, R. H., Hawkins, R. D., Hon, G., Tonti-Filippini, J., et al. (2009). Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462, 315-322. doi: 10.1038/nature08514.
87. Liu, H. C., Hu, C. J., Tang, Y. C., and Chang, J. G. (2008). A pilot study for circadian gene disturbance in dementia patients. Neurosci. Lett. 435, 229-233. doi: 10.1016/j.neulet.2008.02.041.
88. Maeda, T., Guan, J. Z., Oyama, J., Higuchi, Y., and Makino, N. (2009). Aging-associated alteration of subtelomeric methylation in Parkinson's disease. J. Gerontol. A Biol. Sci. Med. Sci. 64, 949-955. doi: 10.1093/gerona/glp070.
89. Mastroeni, D., Grover, A., Delvaux, E., Whiteside, C., Coleman, P. D., and Rogers, J. (2010). Epigenetic changes in Alzheimer's disease: decrements in DNA methylation. Neurobiol. Aging 31, 2025-2037. doi: 10.1016/j.neurobiolaging.2008.12.005.
90. Mastroeni, D., Grover, A., Delvaux, E., Whiteside, C., Coleman, P. D., and Rogers, J. (2011). Epigenetic mechanisms in Alzheimer's disease. Neurobiol. Aging 32, 1161-1180. doi: 10.1016/j.neurobiolaging.2010.08.017.
91. Mastroeni, D., Mckee, A., Grover, A., Rogers, J., and Coleman, P. (2009). Epigenetic differences in cortical neurons from a pair of monozygotic twins discordant for Alzheimer's disease. PLoS ONE 4:e6617. doi: 10.1371/journal.pone.0006617.
92. Matsumoto, L., Takuma, H., Tamaoka, A., Kurisaki, H., Date, H., Tsuji, S., et al. (2010). CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson's disease. PLoS ONE 5:e15522. doi: 10.1371/journal.pone.0015522.
93. Mclean, P. J., Kawamata, H., Ribich, S., and Hyman, B. T. (2000). Membrane association and protein conformation of alpha-synuclein in intact neurons-effect of Parkinson's disease-linked mutations. J. Biol. Chem. 275, 8812-8816. doi: 10.1074/jbc.275.12.8812.
94. Miller, C. A., Campbell, S. L., and Sweatt, J. D. (2008). DNA methylation and histone acetylation work in concert to regulate memory formation and synaptic plasticity. Neurobiol. Learn. Mem. 89, 599-603. doi: 10.1016/j.nlm.2007.07.016.
95. Miller, J., Nadeau, M., Smith, D., and Selhub, J. (1994). Vitamin B-6 deficiency vs. folate deficiency: comparison of responses to methionine loading in rats. Am. J. Clin. Nutr. 59, 1033-1039.
96. Minagawa, H., Watanabe, A., Akatsu, H., Adachi, K., Ohtsuka, C., Terayama, Y., et al. (2010). Homocysteine, another risk factor for Alzheimer disease, impairs apolipoprotein E3 function. J. Biol. Chem. 285, 38382-38388. doi: 10.1074/jbc. M110.146258.
97. Mogi, M., Harada, M., Narabayashi, H., Inagaki, H., Minami, M., and Nagatsu, T. (1996). Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease. Neurosci. Lett. 211, 13-16. doi: 10.1016/0304-3940(96)12706-3.
98. Morahan, J. M., Yu, B., Trent, R. J., and Pamphlett, R. (2007). Are metallothionein genes silenced in ALS? Toxicol. Lett. 168, 83-87. doi: 10.1016/j.toxlet.2006.11.003.
99. Morahan, J. M., Yu, B., Trent, R. J., and Pamphlett, R. (2009). A genome-wide analysis of brain DNA methylation identifies new candidate genes for sporadic amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 10, 418-429. doi: 10.3109/17482960802635397.
100. Ng, C. W., Yildirim, F., Yap, Y. S., Dalin, S., Matthews, B. J., Velez, P. J., et al. (2013). Extensive changes in DNA methylation are associated with expression of mutant huntingtin. Proc. Natl. Acad. Sci. U.S.A. 110, 2354-2359. doi: 10.1073/pnas.1221292110.
101. Nicolia, V., Fuso, A., Cavallaro, R. A., Di Luzio, A., and Scarpa, S. (2010). B vitamin deficiency promotes tau phosphorylation through regulation of GSK3beta and PP2A. J. Alzheimers Dis. 19, 895-907. doi: 10.3233/JAD-2010-1284.
102. Oates, N., and Pamphlett, R. (2007). An epigenetic analysis of SOD1 and VEGF in ALS. Amyotroph. Lateral Scler. 8, 83-86. doi: 10.1080/17482960601149160.
103. Obeid, R., Schadt, A., Dillmann, U., Kostopoulos, P., Fassbender, K., and Herrmann, W. (2009). Methylation status and neurodegenerative markers in Parkinson disease. Clin. Chem. 55, 1852-1860. doi: 10.1373/clinchem.2009.125021.
104. Offe, K., Dodson, S. E., Shoemaker, J. T., Fritz, J. J., Gearing, M., Levey, A. I., et al. (2006). The lipoprotein receptor LR11 regulates amyloid beta production and amyloid precursor protein traffic in endosomal compartments. J. Neurosci. 26, 1596-1603. doi: 10.1523/JNEUROSCI.4946-05.2006.
105. O'Suilleabhain, P. E., Sung, V., Hernandez, C., Lacritz, L., Dewey, B. R., Bottiglieri, T., et al. (2004). Elevated plasma homocysteine level in patients with Parkinson disease. Arch. Neurol. 61, 865-868. doi: 10.1001/archneur.61.6.865.
106. Paul, L. (2011). Diet, nutrition and telomere length. J. Nutr. Biochem. 22, 895-901. doi: 10.1016/j.jnutbio.2010.12.001.
107. Paul, L., Cattaneo, M., D'Angelo, A., Sampietro, F., Fermo, I., Razzari, C., et al. (2009). Telomere length in peripheral blood mononuclear cells is associated with folate status in men. J. Nutr. 139, 1273-1278. doi: 10.3945/jn.109.104984.
108. Penn, N. W., Suwalski, R., O'Riley, C., Bojanowski, K., and Yura, R. (1972). Presence of 5-hydroxymethylcytosine in animal deoxyribonucleic acid. Biochem. J. 126, 781-790.
109. Pieper, H. C., Evert, B. O., Kaut, O., Riederer, P. F., Waha, A., and Wullner, U. (2008). Different methylation of the TNF-alpha promoter in cortex and substantia nigra: Implications for selective neuronal vulnerability. Neurobiol. Dis. 32, 521-527. doi: 10.1016/j.nbd.2008.09.010.
110. Pietrzak, M., Rempala, G., Nelson, P. T., Zheng, J. J., and Hetman, M. (2011). Epigenetic silencing of nucleolar rRNA genes in Alzheimer's disease. PLoS ONE 6:e22585. doi: 10.1371/journal.pone.0022585.
111. Plagnol, V., Nalls, M. A., Bras, J. M., Hernandez, D. G., Sharma, M., Sheerin, U. M., et al. (2011). A two-stage meta-analysis identifies several new loci for Parkinson's disease. PLoS Genet. 7:e1002142. doi: 10.1371/journal.pgen.1002142.
112. Popkie, A. P., Zeidner, L. C., Albrecht, A. M., D'Ippolito, A., Eckardt, S., Newsom, D. E., et al. (2010). Phosphatidylinositol 3-kinase (PI3K) signaling via glycogen synthase kinase-3 (Gsk-3) regulates DNA methylation of imprinted loci. J. Biol. Chem. 285, 41337-41347. doi: 10.1074/jbc. M110.170704.
113. Pritchard, C. A., Cox, D. R., and Myers, R. M. (1989). Methylation at the Huntington disease-linked D4S95 locus. Am. J. Hum. Genet. 45, 335-336.
114. Rao, J. S., Keleshian, V. L., Klein, S., and Rapoport, S. I. (2012). Epigenetic modifications in frontal cortex from Alzheimer's disease and bipolar disorder patients. Transl. Psychiatry 2:e132. doi: 10.1038/tp.2012.55.
115. Reik, W., Dean, W., and Walter, J. (2001). Epigenetic reprogramming in mammalian development. Science 293, 1089-1093. doi: 10.1126/science.1063443.
116. Reik, W., Maher, E. R., Morrison, P. J., Harding, A. E., and Simpson, S. A. (1993). Age at onset in Huntington's disease and methylation at D4S95. J. Med. Genet. 30, 185-188. doi: 10.1136/jmg.30.3.185.
117. Richter, J., Appenzeller, S., Ammerpohl, O., Deuschl, G., Paschen, S., Brueggemann, N., et al. (2012). No evidence for differential methylation of alpha-synuclein in leukocyte DNA of Parkinson's disease patients. Movement Disord. 27, 590-591. doi: 10.1002/mds.24907.
118. Robberecht, W., and Philips, T. (2013). The changing scene of amyotrophic lateral sclerosis. Nat. Rev. Neurosci. 14, 248-264. doi: 10.1038/nrn3430.
119. Roses, A. D., Saunders, A. M., Corder, E. H., Pericakvance, M. A., Han, S. H., Einstein, G., et al. (1995). Influence of the susceptibility genes apolipoprotein E-epsilon 4 and apolipoprotein E-epsilon 2 on the rate of disease expressivity of late-onset Alzheimer's disease. Arzneimittelforschung 45-41, 413-417.
120. Rothstein, J. D., Vankammen, M., Levey, A. I., Martin, L. J., and Kuncl, R. W. (1995). Selective loss of glial glutamate transporter GLT-1 in amyotrophiclateral-sclerosis. Ann. Neurol. 38, 73-84. doi: 10.1002/ana.410380114.
121. Rubinsztein, D. C., and Carmichael, J. (2004). Huntington's disease: molecular basis of neurodegeneration. Expert Rev. Mol. Med. 5, 1-21. doi: 10.1017/S1462399403006549.
122. Scarpa, S., Cavallaro, R. A., D'Anselmi, F., and Fuso, A. (2006). Gene silencing through methylation: an epigenetic intervention on Alzheimer disease. J. Alzheimers Dis. 9, 407-414.
123. Scarpa, S., Fuso, A., D'Anselmi, F., and Cavallaro, R. A. (2003). Presenilin 1 gene silencing by S-adenosylmethionine: a treatment for Alzheimer disease? FEBS Lett. 541, 145-148. doi: 10.1016/S0014-5793(03)00277-1.
124. Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., et al. (2002). Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. New Engl. J. Med. 346, 476-483. doi: 10.1056/NEJMoa011613.
125. Siegmund, K. D., Connor, C. M., Campan, M., Long, T. I., Weisenberger, D. J., Biniszkiewicz, D., et al. (2007). DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons. PLoS ONE 2:e895. doi: 10.1371/journal.pone.0000895.
126. Silva, P. N., Furuya, T. K., Sampaio Braga, I., Rasmussen, L. T., de Labio, R. W., Bertolucci, P. H., et al. (2013). CNP and DPYSL2 mRNA expression and promoter methylation levels in brain of Alzheimer's disease patients. J. Alzheimers Dis. 33, 349-355. doi: 10.3233/JAD-2012-121192.
127. Silva, P. N. O., Gigek, C. O., Leal, M. F., Bertolucci, P. H. F., de Labio, R. W., Payao, S. L. M., et al. (2008). Promoter methylation analysis of SIRT3, SMARCA5, HTERT and CDH1 genes in aging and Alzheimer's disease. J. Alzheimers Dis. 13, 173-176.
128. Speranca, M. A., Batista, L. M., Lourenco Rda, S., Tavares, W. M., Bertolucci, P. H., Rigolin Vde, O., et al. (2008). Can the rDNA methylation pattern be used as a marker for Alzheimer's disease? Alzheimers Dement. 4, 438-442. doi: 10.1016/j.jalz.2008.03.010.
129. Sung, H. Y., Choi, E. N., Ahn Jo, S., Oh, S., and Ahn, J. H. (2011). Amyloid protein-mediated differential DNA methylation status regulates gene expression in Alzheimer's disease model cell line. Biochem. Biophys. Res. Commun. 414, 700-705. doi: 10.1016/j.bbrc.2011.09.136.
130. Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., et al. (2009). Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930-935. doi: 10.1126/science.1170116.
131. Thies, W., Bleiler, L., and Assoc, A. S. (2013). 2013 Alzheimer's disease facts and figures. Alzheimers Dement. 9, 208-245. doi: 10.1016/j.jalz.2013.02.003.
132. Thomas, B., Matson, S., Chopra, V., Sun, L., Sharma, S., Hersch, S., et al. (2013). A novel method for detecting 7-methyl guanine reveals aberrant methylation levels in Huntington disease. Anal. Biochem. 436, 112-120. doi: 10.1016/j.ab.2013.01.035.
133. Twine, N. A., Janitz, K., Wilkins, M. R., and Janitz, M. (2011). Whole transcriptome sequencing reveals gene expression and splicing differences in brain regions affected by Alzheimer's disease. PLoS ONE 6:e16266. doi: 10.1371/journal.pone.0016266.
134. Urdinguio, R. G., Sanchez-Mut, J. V., and Esteller, M. (2009). Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol. 8, 1056-1072. doi: 10.1016/S1474-4422(09)70262-5.
135. van den Hove, D. L. A., Chouliaras, L., and Rutten, B. P. F. (2012). The Role of 5-Hydroxymethylcytosine in aging and Alzheimer's disease: current status and prospects for future studies. Curr. Alzheimer Res. 9, 545-549.
136. van der Flier, W. M., Pijnenburg, Y.a. L., Fox, N. C., and Scheltens, P. (2011). Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE ?4 allele. Lancet Neurol. 10, 280-288. doi: 10.1016/S1474-4422(10)70306-9.
137. van Heesbeen, H. J., Mesman, S., Veenvliet, J. V., and Smidt, M. P. (2013). Epigenetic mechanisms in the development and maintenance of dopaminergic neurons. Development 140, 1159-1169. doi: 10.1242/dev.089359.
138. Villar-Menendez, I., Blanch, M., Tyebji, S., Pereira-Veiga, T., Albasanz, J. L., Martin, M., et al. (2013). Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A(2A)R levels in Huntington's disease. Neuromol. Med. 15, 295-309. doi: 10.1007/s12017-013-8219-0.
139. Voutsinas, G. E., Stavrou, E. F., Karousos, G., Dasoula, A., Papachatzopoulou, A., Syrrou, M., et al. (2010). Allelic imbalance of expression and epigenetic regulation within the alpha-synuclein wild-type and p. Ala53Thr alleles in Parkinson disease. Hum. Mutat. 31, 685-691. doi: 10.1002/humu.21248.
140. Walker, F. O. (2007). Huntington's disease. Lancet 369, 218-228. doi: 10.1016/S0140-6736(07)60111-1.
141. Wang, S. C., Oelze, B., and Schumacher, A. (2008). Age-specific epigenetic drift in late-onset Alzheimer's disease. PLoS ONE 3:e2698. doi: 10.1371/journal.pone.0002698.
142. Wang, Y., Wang, X., Li, R., Yang, Z. F., Wang, Y. Z., Gong, X. L., et al. (2013). A DNA methyltransferase inhibitor, 5-aza-2'-deoxycytidine, exacerbates neurotoxicity and upregulates Parkinson's disease-related genes in dopaminergic neurons. CNS Neurosci. Ther. 19, 183-190. doi: 10.1111/cns.12059.
143. Wasmuth, J. J., Hewitt, J., Smith, B., Allard, D., Haines, J. L., Skarecky, D., et al. (1988). A highly polymorphic locus very tightly linked to the Huntington's disease gene. Nature 332, 734-736. doi: 10.1038/332734a0.
144. Wu, J., Basha, M. R., Brock, B., Cox, D. P., Cardozo-Pelaez, F., Mcpherson, C. A., et al. (2008). Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD. J. Neurosci. 28, 3-9. doi: 10.1523/JNEUROSCI.4405-07.2008.
145. Yang, Y., Gozen, O., Vidensky, S., Robinson, M. B., and Rothstein, J. D. (2010). Epigenetic regulation of neuron-dependent induction of astroglial synaptic protein GLT1. Glia 58, 277-286. doi: 10.1002/glia.20922.
146. Yu, J., Tao, Q., Cheung, K. F., Jin, H., Poon, F. F., Wang, X., et al. (2008). Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors. Hepatology 48, 508-518. doi: 10.1002/hep.22343.
147. Yu, S., Li, X., Liu, G., Han, J., Zhang, C., Li, Y., et al. (2007). Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody. Neuroscience 145, 539-555. doi: 10.1016/j.neuroscience.2006.12.028.
148. Zajac, M. S., Pang, T. Y., Wong, N., Weinrich, B., Leang, L. S., Craig, J. M., et al. (2010). Wheel running and environmental enrichment differentially modify exon-specific BDNF expression in the hippocampus of wild-type and pre-motor symptomatic male and female Huntington's disease mice. Hippocampus 20, 621-636. doi: 10.1002/hipo.20658.
149. Zhang, W., Tian, Z., Sha, S., Cheng, L. Y. L., Philipsen, S., and Tan-Un, K.-C. (2011). Functional and sequence analysis of human neuroglobin gene promoter region. BBA 1809, 236-244. doi: 10.1016/j.bbagrm.2011.02.003.